KM

Kunal Mandloi

Active Director Director DIN 10823567
DIN 10823567 First appointment Oct 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Kunal Mandloi

Data last updated:

Kunal Mandloi is a Director at Neofem Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10823567
Primary Designation Director
Industry Pharma
First Appointment 29 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Oct 20242024Active

Directorship timeline

Open interactive timeline →
Neofem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kunal Mandloi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kunal Mandloi

Kunal Mandloi currently holds 1 directorship: Neofem Pharmaceuticals Private Limited (Director, since 29 Oct 2024).

Kunal Mandloi was first appointed on 29 Oct 2024 as Director at Neofem Pharmaceuticals Private Limited.

The current boards of Kunal Mandloi's companies include Abhimanyu Mahajan (Neofem Pharmaceuticals Private Limited), Ankit Gupta (Neofem Pharmaceuticals Private Limited), Jitendra Kumar Dashore (Neofem Pharmaceuticals Private Limited), Kapil Mahajan (Neofem Pharmaceuticals Private Limited), Priyank Kumar Moyade (Neofem Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available